Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses
Meng-Long Zhou,1,2,* Wang Yang,1,2,* Ya-Qi Wang,1,2,* Miao Mo,2,3 Ran Hu,1,2 Yan Wang,1,2 Jia-Ning Yang,1,2 Gui-Chao Li,1,2 Ya-Nong Wang,2,4 Zhen Zhang1,21Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China; 2Department of...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-05-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/adjuvant-chemoradiotherapy-versus-adjuvant-chemotherapy-for-patients-w-peer-reviewed-article-CMAR |
id |
doaj-5218b7c267ea47ae8f2c4b691c224b54 |
---|---|
record_format |
Article |
spelling |
doaj-5218b7c267ea47ae8f2c4b691c224b542020-11-24T21:30:49ZengDove Medical PressCancer Management and Research1179-13222019-05-01Volume 114855487046117Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analysesZhou MLYang WWang YQMo MHu RWang YYang JNLi GCWang YNZhang ZMeng-Long Zhou,1,2,* Wang Yang,1,2,* Ya-Qi Wang,1,2,* Miao Mo,2,3 Ran Hu,1,2 Yan Wang,1,2 Jia-Ning Yang,1,2 Gui-Chao Li,1,2 Ya-Nong Wang,2,4 Zhen Zhang1,21Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China; 3Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China; 4Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China*These authors contributed equally to this workPurpose: N3 gastric cancer (GC) is characterized by a heavy burden of lymph node metastasis and a high postoperative recurrence rate. The role of radiotherapy in this group of patients remains undetermined. The purpose of this study was to compare the effectiveness of adjuvant chemoradiotherapy (CRT) and adjuvant chemotherapy (ChT) for N3 GC after D2/R0 resection.Patients and methods: From January 2004 to December 2015, patients with N3 GC in the database of Fudan University Shanghai Cancer Center were retrospectively reviewed. The eligible patients were enrolled in an adjuvant CRT group and an adjuvant ChT group. Four different methods based on a propensity score model were used to balance the baseline characteristics. Then, survival analyses between the two groups were performed in addition to patterns of recurrence and subgroup analyses.Results: In total, 175 and 365 eligible patients were enrolled into the CRT and ChT groups, respectively. After balancing, the disease-free survival (DFS) of patients in the CRT group was significantly better than that of patients in the ChT group (p=0.021). Subgroup analyses showed that patients with N3a GC benefitted from adjuvant CRT.Conclusion: Compared with adjuvant ChT, adjuvant CRT can further improve the DFS of patients with N3 GC after D2/R0 resection. Patients with lymph node metastases should be further stratified when selecting patients for adjuvant CRT.Keywords: stomach neoplasms, gastrectomy, chemoradiation, propensity score, survival analysis https://www.dovepress.com/adjuvant-chemoradiotherapy-versus-adjuvant-chemotherapy-for-patients-w-peer-reviewed-article-CMARstomach neoplasmsgastrectomychemoradiationpropensity scoresurvival analysis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhou ML Yang W Wang YQ Mo M Hu R Wang Y Yang JN Li GC Wang YN Zhang Z |
spellingShingle |
Zhou ML Yang W Wang YQ Mo M Hu R Wang Y Yang JN Li GC Wang YN Zhang Z Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses Cancer Management and Research stomach neoplasms gastrectomy chemoradiation propensity score survival analysis |
author_facet |
Zhou ML Yang W Wang YQ Mo M Hu R Wang Y Yang JN Li GC Wang YN Zhang Z |
author_sort |
Zhou ML |
title |
Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses |
title_short |
Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses |
title_full |
Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses |
title_fullStr |
Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses |
title_full_unstemmed |
Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses |
title_sort |
adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with n3 gastric cancer after d2/r0 resection: a retrospective study based on propensity score analyses |
publisher |
Dove Medical Press |
series |
Cancer Management and Research |
issn |
1179-1322 |
publishDate |
2019-05-01 |
description |
Meng-Long Zhou,1,2,* Wang Yang,1,2,* Ya-Qi Wang,1,2,* Miao Mo,2,3 Ran Hu,1,2 Yan Wang,1,2 Jia-Ning Yang,1,2 Gui-Chao Li,1,2 Ya-Nong Wang,2,4 Zhen Zhang1,21Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China; 3Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China; 4Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China*These authors contributed equally to this workPurpose: N3 gastric cancer (GC) is characterized by a heavy burden of lymph node metastasis and a high postoperative recurrence rate. The role of radiotherapy in this group of patients remains undetermined. The purpose of this study was to compare the effectiveness of adjuvant chemoradiotherapy (CRT) and adjuvant chemotherapy (ChT) for N3 GC after D2/R0 resection.Patients and methods: From January 2004 to December 2015, patients with N3 GC in the database of Fudan University Shanghai Cancer Center were retrospectively reviewed. The eligible patients were enrolled in an adjuvant CRT group and an adjuvant ChT group. Four different methods based on a propensity score model were used to balance the baseline characteristics. Then, survival analyses between the two groups were performed in addition to patterns of recurrence and subgroup analyses.Results: In total, 175 and 365 eligible patients were enrolled into the CRT and ChT groups, respectively. After balancing, the disease-free survival (DFS) of patients in the CRT group was significantly better than that of patients in the ChT group (p=0.021). Subgroup analyses showed that patients with N3a GC benefitted from adjuvant CRT.Conclusion: Compared with adjuvant ChT, adjuvant CRT can further improve the DFS of patients with N3 GC after D2/R0 resection. Patients with lymph node metastases should be further stratified when selecting patients for adjuvant CRT.Keywords: stomach neoplasms, gastrectomy, chemoradiation, propensity score, survival analysis |
topic |
stomach neoplasms gastrectomy chemoradiation propensity score survival analysis |
url |
https://www.dovepress.com/adjuvant-chemoradiotherapy-versus-adjuvant-chemotherapy-for-patients-w-peer-reviewed-article-CMAR |
work_keys_str_mv |
AT zhouml adjuvantchemoradiotherapyversusadjuvantchemotherapyforpatientswithn3gastriccancerafterd2r0resectionaretrospectivestudybasedonpropensityscoreanalyses AT yangw adjuvantchemoradiotherapyversusadjuvantchemotherapyforpatientswithn3gastriccancerafterd2r0resectionaretrospectivestudybasedonpropensityscoreanalyses AT wangyq adjuvantchemoradiotherapyversusadjuvantchemotherapyforpatientswithn3gastriccancerafterd2r0resectionaretrospectivestudybasedonpropensityscoreanalyses AT mom adjuvantchemoradiotherapyversusadjuvantchemotherapyforpatientswithn3gastriccancerafterd2r0resectionaretrospectivestudybasedonpropensityscoreanalyses AT hur adjuvantchemoradiotherapyversusadjuvantchemotherapyforpatientswithn3gastriccancerafterd2r0resectionaretrospectivestudybasedonpropensityscoreanalyses AT wangy adjuvantchemoradiotherapyversusadjuvantchemotherapyforpatientswithn3gastriccancerafterd2r0resectionaretrospectivestudybasedonpropensityscoreanalyses AT yangjn adjuvantchemoradiotherapyversusadjuvantchemotherapyforpatientswithn3gastriccancerafterd2r0resectionaretrospectivestudybasedonpropensityscoreanalyses AT ligc adjuvantchemoradiotherapyversusadjuvantchemotherapyforpatientswithn3gastriccancerafterd2r0resectionaretrospectivestudybasedonpropensityscoreanalyses AT wangyn adjuvantchemoradiotherapyversusadjuvantchemotherapyforpatientswithn3gastriccancerafterd2r0resectionaretrospectivestudybasedonpropensityscoreanalyses AT zhangz adjuvantchemoradiotherapyversusadjuvantchemotherapyforpatientswithn3gastriccancerafterd2r0resectionaretrospectivestudybasedonpropensityscoreanalyses |
_version_ |
1725961647230550016 |